Sterling Capital Management’s Idexx Laboratories IDXX Stock Holding History

Sterling Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.05M	Buy	3,902 +609	+18%	+$342K	0.03%	355
2026 Q1	$1.85M	Sell	3,293 -1,779	-35%	-$1.14M	0.04%	349
2025 Q4	$3.43M	Sell	5,072 -5,421	-52%	-$3.69M	0.06%	250
2025 Q3	$6.7M	Buy	10,493 +2,315	+28%	+$1.41M	0.1%	135
2025 Q2	$4.39M	Sell	8,178 -859	-10%	-$411K	0.06%	216
2025 Q1	$3.8M	Sell	9,037 -1,390	-13%	-$604K	0.06%	224
2024 Q4	$4.31M	Buy	10,427 +1,597	+18%	+$700K	0.06%	250
2024 Q3	$4.46M	Buy	+8,830	New	+$4.29M	0.06%	238
2019 Q3	$7.61M	Buy	28,000 +6,020	+27%	+$1.68M	0.07%	209
2019 Q2	$6.05M	Hold	21,980	–	–	0.06%	232
2019 Q1	$4.92M	Hold	21,980	–	–	0.05%	245
2018 Q4	$4.09M	Buy	+21,980	New	+$4.51M	0.04%	248

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sterling Capital Management's IDXX Position: Q2 2026 in Review

Sterling Capital Management increased its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, buying an estimated $342K and bringing the position to 3,902 shares worth $2.05M. The position accounts for 0.03% of the portfolio, ranked #355.

Sterling Capital Management first reported a position in IDXX in Q4 2018 and has held it in 12 quarters since. The position peaked at $7.61M in Q3 2019. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Sterling Capital Management held 3,902 shares of Idexx Laboratories worth $2.05M as of Q2 2026.
Sterling Capital Management bought 609 Idexx Laboratories shares in Q2 2026, an estimated $342K.
Idexx Laboratories made up 0.03% of Sterling Capital Management's portfolio in Q2 2026, its #355 holding.
Sterling Capital Management first reported a position in Idexx Laboratories in Q4 2018 and has held it in 12 quarters since.
Sterling Capital Management's Idexx Laboratories position peaked at $7.61M in Q3 2019.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.